"The efficacy, safety and cost-effectiveness of hydroxychloroquine, ..."

Juan Zhao et al. (2021)

> Home

Details and statistics

DOI: 10.1186/S12911-021-01449-2

access: open

type: Journal Article

metadata version: 2021-10-14

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/midm/ZhaoZWJYYZ21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/midm/ZhaoZWJYYZ21
Juan Zhao, Wei Zhou, Yangfeng Wu, Ping Ji, Li Yang, Xiaoyan Yan, Zhuoli Zhang:
The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study). BMC Medical Informatics Decis. Mak. 21(1): 83 (2021)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.